You have no items in your shopping cart.
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein
Description
Images & Validation
−| Tested Applications | ELISA, WB |
|---|---|
| Application Notes |
Key Properties
−| Source | HEK293 cells |
|---|---|
| Tag | His-Avi |
| Protein Sequence | Val16-Arg685 (N501Y) |
| Purity | > 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLCEndotoxin level is less than 1EU per ug by the LAL method. |
Storage & Handling
−| Storage | Store in working aliquots at -20˚°C. Avoid freeze/thaw cycles. |
|---|---|
| Form/Appearance | Lyophilized |
| Buffer/Preservatives | 20mM PB (pH 7.4). 5 % trehalose is added as protectant before lyophilization. |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Immobilized SARS-CoV S protein RBD (N501Y), His Tag at 0.5 ug/ml (100ug/Well) on the plate. Dose response curve for Human ACE2, Fc Tag with the EC50 of 80.3 ng/ml determined by ELISA.

The purity of SARS-COV-2 S protein Spike S1 (N501Y) is greater than 95% as determiend by SEC-HPLC.

SARS-COV2 S protein Spike S1 (N501Y) on Tris-Bis PAGE under reduced condition. The purity is great than 95%.
Quick Database Links
NCBI Reference Sequences
−| RefSeq | YP_009724390.1 |
|---|
Documents Download
Request a Document
Protocol Information
SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) Spike S1 (N501Y) Recombinant Protein (orb1231543)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review